Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Validation of T2- and diffusion-weighted magnetic resonance imaging for mapping intra-prostatic tumour prior to focal boost dose-escalation using intensity-modulated radiotherapy (IMRT).
Alexander EJ, Murray JR, Morgan VA, Giles SL, Riches SF, Hazell S, Thomas K, Sohaib SA, Thompson A, Gao A, Dearnaley DP, DeSouza NM. Alexander EJ, et al. Radiother Oncol. 2019 Dec;141:181-187. doi: 10.1016/j.radonc.2019.07.030. Epub 2019 Sep 5. Radiother Oncol. 2019. PMID: 31493904 Free PMC article.
Standard and Hypofractionated Dose Escalation to Intraprostatic Tumor Nodules in Localized Prostate Cancer: Efficacy and Toxicity in the DELINEATE Trial.
Murray JR, Tree AC, Alexander EJ, Sohaib A, Hazell S, Thomas K, Gunapala R, Parker CC, Huddart RA, Gao A, Truelove L, McNair HA, Blasiak-Wal I, deSouza NM, Dearnaley D. Murray JR, et al. Among authors: alexander ej. Int J Radiat Oncol Biol Phys. 2020 Mar 15;106(4):715-724. doi: 10.1016/j.ijrobp.2019.11.402. Epub 2019 Dec 5. Int J Radiat Oncol Biol Phys. 2020. PMID: 31812718 Free article. Clinical Trial.
Standard and Hypofractionated Dose Escalation to Intraprostatic Tumor Nodules in Localized Prostate Cancer: 5-Year Efficacy and Toxicity in the DELINEATE Trial.
Tree AC, Satchwell L, Alexander E, Blasiak-Wal I, deSouza NM, Gao A, Greenlay E, McNair H, Parker C, Talbot J, Dearnaley D, Murray J. Tree AC, et al. Int J Radiat Oncol Biol Phys. 2023 Feb 1;115(2):305-316. doi: 10.1016/j.ijrobp.2022.09.058. Epub 2022 Sep 21. Int J Radiat Oncol Biol Phys. 2023. PMID: 36150450 Clinical Trial.
Early interval and serial positron emission tomography-computed tomography (PET-CT) after an indeterminate response defined by a PET scored 4 on the Deauville scale in lymphoma.
Kumar R, Hujairi N, Mohammed K, Attygalle A, Alexander E, Chau I, Cunningham D, Iyengar S, El-Sharkawi D, Sharma B. Kumar R, et al. Br J Haematol. 2020 Sep;190(6):e357-e362. doi: 10.1111/bjh.16919. Epub 2020 Jul 8. Br J Haematol. 2020. PMID: 32643153 Free article. No abstract available.
A wolf in sheep's clothing: enteropathy associated T-cell lymphoma involving a nasal polyp masquerading as primary mucosal CD30-positive T-cell lymphoproliferative disorder.
Attygalle AD, Vroobel KM, Madej E, Tzioni MM, Zhang C, Chen Z, Ribeiro S, Calvachini S, Sharma B, Alexander EJ, Wotherspoon AC, Du MQ. Attygalle AD, et al. Among authors: alexander ej. Histopathology. 2024 Jun;84(7):1238-1241. doi: 10.1111/his.15161. Epub 2024 Feb 21. Histopathology. 2024. PMID: 38383998 No abstract available.
40 results